Color Genomics Captures $45M For Genetic Testing For Cancer Risk
Burlingame-basd Color, a company which offers up genetic testing for cancer risk to the general public, has raised $45M in a Series B funding. The funding was led by General Catalyst, and also included U2's Bono, along with Susan L. Wagner, 8VC, Khosla Ventures and Emerson Collective. As part of the funding, Susan Wagner (formerly of BlackRock) and Hemant Taneja (General Catalyst) both join the company's board. Color is led by Elad Gil.
posted on Tuesday, September 27, 2016 (Link to more information)
Related companies:
Color
Related stories:
> Color Genomics Raises $50M In $80M Round
> Trace Genomics Digs Up $4M For Soil Microbe Testing
> MedGenome Raises $30M
> Counsyl Gets $28M For Genetic Testing Service
> Boreal Genomics Gets $18M For Cancer Profiling
silicontap.com Home